The ATLET Study: Can Subjects With Incomplete Spinal Cord Injury Learn to Walk?

NCT00854555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-09-11

No results posted yet for this study

Summary

The ATLET study will assess the effect of manual or robotic body-weight supported locomotor training of patients with stable motor incomplete spinal cord injury (SCI) on gait and overall ADL function as well as on estimated health care costs.

Conditions

  • Spinal Cord Injury

Interventions

OTHER

Locomotor training with robot

60 days locomotor training during 6 months period in out-patient setting. Minimum 60 min training up to 3 times per week. Control group receives conventional training/treatment.

OTHER

Locomotor training with manual assistance

60 days training during 6 months period on in-patient setting. Training 2 times per day total 120 minutes. Control group receives conventional training/treatment.

Sponsors & Collaborators

  • Sunnaas Rehabilitation Hospital

    collaborator OTHER
  • Norwegian School of Sport Sciences

    collaborator OTHER
  • University of Tromso

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Norwegian Foundation for Health and Rehabilitation

    collaborator OTHER
  • Norwegian Department of Health and Social Affairs

    collaborator OTHER_GOV
  • Loma Linda University

    collaborator OTHER
  • North Norway Rehabilitation Center

    lead OTHER

Principal Investigators

  • Synnove F Knutsen, MD PhD · North Norway Rehabilitation Center

  • Raymond Knutsen, MD MPH · ATLET Steering group

  • Nils Hjeltnes, MD PhD · Sunnaas Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2018-12-31
Completion
2019-01-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00854555 on ClinicalTrials.gov